within Pharmacolibrary.Drugs.ATC.L;

model L02AB02
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 3.833333333333334e-06,
    adminDuration  = 600,
    adminMass      = 150 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.03,
    k12             = 0.45,
    k21             = 0.45
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L02AB02</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Medroxyprogesterone is a synthetic progestogen (progestin) used primarily in hormone therapy, contraception, the treatment of endometriosis, and certain cancers. It is available in oral, intramuscular, and subcutaneous forms. Medroxyprogesterone acetate (MPA) is the most common ester and is widely approved for medical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters refer to healthy female volunteers after a single intramuscular injection of medroxyprogesterone acetate (MPA), generally corresponding to depot contraceptive administration.</p><h4>References</h4><ol><li><p>Mishell, DR (1996). Pharmacokinetics of depot medroxyprogesterone acetate contraception. <i>The Journal of reproductive medicine</i> 41(5 Suppl) 381–390. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8725700/\">https://pubmed.ncbi.nlm.nih.gov/8725700</a></p></li><li><p>Sierra-Ramírez, JA, et al., &amp; Garza-Flores, J (2011). Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg). <i>Contraception</i> 84(6) 565–570. DOI:<a href=\"https://doi.org/10.1016/j.contraception.2011.03.014\">10.1016/j.contraception.2011.03.014</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22078184/\">https://pubmed.ncbi.nlm.nih.gov/22078184</a></p></li><li><p>Bick, AJ, et al., &amp; Hapgood, JP (2022). Variability and quantification of serum medroxyprogesterone acetate levels. <i>Steroids</i> 187 109100–None. DOI:<a href=\"https://doi.org/10.1016/j.steroids.2022.109100\">10.1016/j.steroids.2022.109100</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35964796/\">https://pubmed.ncbi.nlm.nih.gov/35964796</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L02AB02;
